Computational Identification of Small Interfering RNA Targets in SARS-CoV-2.
作者信息
Chen Wei, Feng Pengmian, Liu Kewei, Wu Meng, Lin Hao
机构信息
Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Center for Genomics and Computational Biology, School of Life Sciences, North China University of Science and Technology, Tangshan, 063210, China.
出版信息
Virol Sin. 2020 Jun;35(3):359-361. doi: 10.1007/s12250-020-00221-6. Epub 2020 Apr 15.
Abstract
摘要
相似文献
1
Computational Identification of Small Interfering RNA Targets in SARS-CoV-2.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）中小干扰RNA靶点的计算鉴定
Virol Sin. 2020 Jun;35(3):359-361. doi: 10.1007/s12250-020-00221-6. Epub 2020 Apr 15.
2
[Evaluation of different genes in the RT-PCR detection of SARS-CoV-2 in respiratory samples and its evolution in infection].[呼吸道样本中SARS-CoV-2的RT-PCR检测中不同基因的评估及其在感染中的演变]
Rev Esp Quimioter. 2020 Aug;33(4):292-293. doi: 10.37201/req/045.2020. Epub 2020 May 27.
3
Cohort PCR Testing: A Strategic Method for Rapid SARS-CoV-2 Screening.队列聚合酶链反应检测：一种快速筛查严重急性呼吸综合征冠状病毒2的策略性方法。
Am J Clin Pathol. 2020 Jul 7;154(2):278-279. doi: 10.1093/ajcp/aqaa092.
4
Development of transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India.转录RNA作为印度SARS-CoV-2实验室诊断阳性对照的开发。
Indian J Med Res. 2020;151(2 & 3):251-254. doi: 10.4103/ijmr.IJMR_671_20.
5
Evaluation of & -based real-time RT-PCR assays for confirmation of SARS-CoV-2 infection: An observational study.基于&的实时逆转录聚合酶链反应检测法用于确诊新型冠状病毒2019感染的评估：一项观察性研究。 （注：原文中“&”处信息缺失，可能影响对完整内容的准确理解）
Indian J Med Res. 2020 May;151(5):483-485. doi: 10.4103/ijmr.IJMR_1256_20.
6
The origin of SARS-CoV-2.严重急性呼吸综合征冠状病毒2的起源。
Lancet Infect Dis. 2020 Sep;20(9):1018-1019. doi: 10.1016/S1473-3099(20)30641-1.
7
Duration of SARS-CoV-2 viral RNA in asymptomatic carriers.无症状携带者中新冠病毒RNA的持续时间。
Crit Care. 2020 May 24;24(1):245. doi: 10.1186/s13054-020-02952-0.
8
Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).无症状冠状病毒感染：中东呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒2（新型冠状病毒肺炎）
Travel Med Infect Dis. 2020 May-Jun;35:101608. doi: 10.1016/j.tmaid.2020.101608. Epub 2020 Feb 27.
9
Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2.新型冠状病毒SARS-CoV-2高变基因组热点的鉴定。
J Infect. 2020 Jun;80(6):671-693. doi: 10.1016/j.jinf.2020.02.027. Epub 2020 Mar 5.
10
From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.从 SARS 和 MERS CoVs 到 SARS-CoV-2：病毒结构和非结构基因中更偏向于使用密码子。
J Med Virol. 2020 Jun;92(6):660-666. doi: 10.1002/jmv.25754. Epub 2020 Mar 16.
引用本文的文献
1
Therapeutic Approaches of Viral Gene Silencing by Small Interfering RNA: Strategies to Prevent the Emergence of Antiviral Resistant Escape Mutants.小干扰RNA介导的病毒基因沉默治疗方法：预防抗病毒耐药逃逸突变体出现的策略
Pharmaceuticals (Basel). 2025 Jul 1;18(7):987. doi: 10.3390/ph18070987.
2
DeepEpiIL13: Deep Learning for Rapid and Accurate Prediction of IL-13-Inducing Epitopes Using Pretrained Language Models and Multiwindow Convolutional Neural Networks.DeepEpiIL13：使用预训练语言模型和多窗口卷积神经网络对诱导白细胞介素-13的表位进行快速准确预测的深度学习方法
ACS Omega. 2025 Feb 26;10(9):9675-9683. doi: 10.1021/acsomega.4c10960. eCollection 2025 Mar 11.
3
RNAi-Induced Gene Silencing against Chikungunya and COVID-19: What Have We Learned So Far, and What Is the Way Forward?RNAi 诱导的基对基因沉默对基孔肯雅热和 COVID-19：我们迄今为止学到了什么，以及未来的路是什么？
Viruses. 2024 Sep 20;16(9):1489. doi: 10.3390/v16091489.
4
Potential of siRNA in COVID-19 therapy: Emphasis on design and nanoparticles based delivery.siRNA在COVID-19治疗中的潜力：重点在于设计和基于纳米颗粒的递送。
Front Bioeng Biotechnol. 2023 Feb 6;11:1112755. doi: 10.3389/fbioe.2023.1112755. eCollection 2023.
5
siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases.用于疾病管理的小干扰RNA功能化脂质纳米颗粒（LNPs）
Pharmaceutics. 2022 Nov 19;14(11):2520. doi: 10.3390/pharmaceutics14112520.
6
In silico prediction and experimental evaluation of potential siRNAs against SARS-CoV-2 inhibition in Vero E6 cells.针对Vero E6细胞中抑制严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的潜在小干扰RNA（siRNA）的计算机预测及实验评估
J King Saud Univ Sci. 2022 Jun;34(4):102049. doi: 10.1016/j.jksus.2022.102049. Epub 2022 Apr 26.
7
Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm.针对细胞因子风暴的基于核酸的新冠病毒治疗：平息风暴的策略
J Pers Med. 2022 Mar 3;12(3):386. doi: 10.3390/jpm12030386.
8
Effect of insilico predicted and designed potential siRNAs on inhibition of SARS-CoV-2 in HEK-293 cells.计算机预测和设计的潜在小干扰RNA对人胚肾293细胞中新型冠状病毒抑制作用的影响
J King Saud Univ Sci. 2022 Jun;34(4):101965. doi: 10.1016/j.jksus.2022.101965. Epub 2022 Mar 16.
9
Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2.预防新型冠状病毒摄取和复制的小干扰RNA的筛选与验证
Front Bioeng Biotechnol. 2022 Mar 2;10:801870. doi: 10.3389/fbioe.2022.801870. eCollection 2022.
10
Antisense technology as a potential strategy for the treatment of coronaviruses infection: With focus on COVID-19.反义核酸技术作为一种治疗冠状病毒感染的潜在策略：聚焦 COVID-19。
IET Nanobiotechnol. 2022 May;16(3):67-77. doi: 10.1049/nbt2.12079. Epub 2022 Mar 10.
本文引用的文献
1
The 2019 novel coronavirus resource.2019新型冠状病毒资源
Yi Chuan. 2020 Feb 20;42(2):212-221. doi: 10.16288/j.yczz.20-030.
2
Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses.以毒攻毒：一种针对2019新型冠状病毒（SARS-CoV-2）及其他RNA病毒的潜在疗法。
Cell Res. 2020 Mar;30(3):189-190. doi: 10.1038/s41422-020-0290-0.
3
Novel coronavirus: From discovery to clinical diagnostics.新型冠状病毒：从发现到临床诊断。
Infect Genet Evol. 2020 Apr;79:104211. doi: 10.1016/j.meegid.2020.104211. Epub 2020 Jan 30.
4
The 2019-new coronavirus epidemic: Evidence for virus evolution.2019 新型冠状病毒疫情：病毒进化的证据。
J Med Virol. 2020 Apr;92(4):455-459. doi: 10.1002/jmv.25688. Epub 2020 Feb 7.
5
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
6
RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?基于 RNA 干扰 (RNAi) 的治疗方法：是否兑现了承诺？
Annu Rev Pharmacol Toxicol. 2016;56:103-22. doi: 10.1146/annurev-pharmtox-010715-103633.
7
RNAstructure: Web servers for RNA secondary structure prediction and analysis.RNAstructure：用于 RNA 二级结构预测和分析的网络服务器。
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W471-4. doi: 10.1093/nar/gkt290. Epub 2013 Apr 24.
8
Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications.癌症中的小干扰RNA疗法：作用机制、潜在靶点及临床应用
Expert Opin Ther Targets. 2008 May;12(5):637-45. doi: 10.1517/14728222.12.5.637.
9
Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs.合成小干扰RNA对严重急性呼吸综合征冠状病毒基因表达的抑制作用。
Cell Res. 2005 Mar;15(3):193-200. doi: 10.1038/sj.cr.7290286.
10
siRNA targeting the leader sequence of SARS-CoV inhibits virus replication.靶向严重急性呼吸综合征冠状病毒前导序列的小干扰RNA抑制病毒复制。
Gene Ther. 2005 May;12(9):751-61. doi: 10.1038/sj.gt.3302479.
Zotero 插件